1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033
5.3.1. Antibody Development
5.3.2. Antibody Production & Purification
5.3.3. Antibody Fragmentation & Labeling
5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022
5.5. Absolute $ Opportunity Analysis By Service, 2023-2033
6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Antibodies
6.3.4. Other Custom Antibodies
6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Type, 2023-2033
7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
7.3.1. Mice
7.3.2. Rabbits
7.3.3. Other Sources
7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Neurobiology
8.3.4. Stem Cells
8.3.5. Immunology
8.3.6. Cardiovascular Disease
8.3.7. Other Research Areas
8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022
8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033
9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. Academic & Research Institutes
9.3.3. Contract Research Organizations
9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Service
11.2.3. By Type
11.2.4. By Source
11.2.5. By Research Area
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Service
11.3.3. By Type
11.3.4. By Source
11.3.5. By Research Area
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Service
12.2.3. By Type
12.2.4. By Source
12.2.5. By Research Area
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Service
12.3.3. By Type
12.3.4. By Source
12.3.5. By Research Area
12.3.6. By End User
12.4. Key Takeaways
13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. U.K.
13.2.1.2. Spain
13.2.1.3. Germany
13.2.1.4. Italy
13.2.1.5. France
13.2.1.6. Rest of Europe
13.2.2. By Service
13.2.3. By Type
13.2.4. By Source
13.2.5. By Research Area
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Service
13.3.3. By Type
13.3.4. By Source
13.3.5. By Research Area
13.3.6. By End User
13.4. Key Takeaways
14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. India
14.2.1.4. Rest of Asia Pacific
14.2.2. By Service
14.2.3. By Type
14.2.4. By Source
14.2.5. By Research Area
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Service
14.3.3. By Type
14.3.4. By Source
14.3.5. By Research Area
14.3.6. By End User
14.4. Key Takeaways
15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. GCC Countries
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Service
15.2.3. By Type
15.2.4. By Source
15.2.5. By Research Area
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Service
15.3.3. By Type
15.3.4. By Source
15.3.5. By Research Area
15.3.6. By End User
15.4. Key Takeaways
16. Key Countries Custom Antibody Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Service
16.1.2.2. By Type
16.1.2.3. By Source
16.1.2.4. By Research Area
16.1.2.5. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Service
16.2.2.2. By Type
16.2.2.3. By Source
16.2.2.4. By Research Area
16.2.2.5. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Service
16.3.2.2. By Type
16.3.2.3. By Source
16.3.2.4. By Research Area
16.3.2.5. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Service
16.4.2.2. By Type
16.4.2.3. By Source
16.4.2.4. By Research Area
16.4.2.5. By End User
16.5. U.K.
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Service
16.5.2.2. By Type
16.5.2.3. By Source
16.5.2.4. By Research Area
16.5.2.5. By End User
16.6. Spain
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Service
16.6.2.2. By Type
16.6.2.3. By Source
16.6.2.4. By Research Area
16.6.2.5. By End User
16.7. Germany
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Service
16.7.2.2. By Type
16.7.2.3. By Source
16.7.2.4. By Research Area
16.7.2.5. By End User
16.8. Italy
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Service
16.8.2.2. By Type
16.8.2.3. By Source
16.8.2.4. By Research Area
16.8.2.5. By End User
16.9. France
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Service
16.9.2.2. By Type
16.9.2.3. By Source
16.9.2.4. By Research Area
16.9.2.5. By End User
16.10. China
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Service
16.10.2.2. By Type
16.10.2.3. By Source
16.10.2.4. By Research Area
16.10.2.5. By End User
16.11. Japan
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Service
16.11.2.2. By Type
16.11.2.3. By Source
16.11.2.4. By Research Area
16.11.2.5. By End User
16.12. India
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Service
16.12.2.2. By Type
16.12.2.3. By Source
16.12.2.4. By Research Area
16.12.2.5. By End User
16.13. South Africa
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Service
16.13.2.2. By Type
16.13.2.3. By Source
16.13.2.4. By Research Area
16.13.2.5. By End User
16.14. GCC Countries
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Service
16.14.2.2. By Type
16.14.2.3. By Source
16.14.2.4. By Research Area
16.14.2.5. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Service
17.3.3. By Type
17.3.4. By Source
17.3.5. By Research Area
17.3.6. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Thermo Fisher Scientific
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Bio-Rad Laboratories Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Merck Group
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Cell Signaling Technology, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. GenScript
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. BioLegend
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Abcam Plc
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Agilent Technologies
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Innovagen AB
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Proteogenix
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Bio-Techne
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Creative Diagnostics
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Sino Biological, Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Raybiotech, Inc.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. ProSci Incorporated
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Table 1: Global Custom Antibody Market Value (US$ Million) Forecast by Region, 2018-2033
Table 2: Global Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 3: Global Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 4: Global Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 5: Global Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 6: Global Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
Table 7: North America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033
Table 8: North America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 9: North America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 10: North America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 11: North America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 12: North America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
Table 13: Latin America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033
Table 14: Latin America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 15: Latin America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 16: Latin America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 17: Latin America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 18: Latin America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
Table 19: Europe Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033
Table 20: Europe Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 21: Europe Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 22: Europe Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 23: Europe Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 24: Europe Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
Table 25: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033
Table 26: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 27: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 28: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 29: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 30: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
Table 31: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033
Table 32: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033
Table 33: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033
Table 34: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033
Table 35: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033
Table 36: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/